➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Fasinumab

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Fasinumab?

Fasinumab is an investigational drug.

There have been 10 clinical trials for Fasinumab. The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Osteoarthritis, Osteoarthritis, Hip, and Osteoarthritis, Knee. The leading clinical trial sponsors are Regeneron Pharmaceuticals, Teva Pharmaceutical Industries, Ltd., and Mitsubishi Tanabe Pharma Corporation.

There are two US patents protecting this investigational drug.

Recent Clinical Trials for Fasinumab
Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and HipTeva Pharmaceutical Industries, Ltd.Phase 2
Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and HipRegeneron PharmaceuticalsPhase 2
To Assess the Patients' Ability to Self-Administer Fasinumab in an Unsupervised SettingRegeneron PharmaceuticalsPhase 3

See all Fasinumab clinical trials

Clinical Trial Summary for Fasinumab

Top disease conditions for Fasinumab
Top clinical trial sponsors for Fasinumab

See all Fasinumab clinical trials

US Patents for Fasinumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fasinumab   Get Started Free Binding-triggered transcriptional switches and methods of use thereof The Regents of the University of California (Oakland, CA)   Get Started Free
Fasinumab   Get Started Free Cell culture medium LA JOLLA BIOLOGICS, INC. (San Diego, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.